Spots Global Cancer Trial Database for Inflammatory Cytokines in Symptom Production in Multiple Myeloma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Inflammatory Cytokines in Symptom Production in Multiple Myeloma

Official Title: Identifying the Role of Inflammatory Cytokines in Symptom Production in Multiple Myeloma

Study ID: NCT00688168

Conditions

Multiple Myeloma

Interventions

Questionnaire

Neurocognitive Testing

Neurosensory Testing

Study Description

Brief Summary: The goal of this research study is to learn about the pain and/or other symptoms that patients may experience either while you are being monitored by your doctor before a decision is made to start you on treatment for your MM, or during and after treatment for MM, and how these symptoms may affect therapy. A second goal is to learn how differences in genes may affect the symptom burden from cancer and cancer therapy.

Detailed Description: If you agree to take part in this study, you will complete 5 questionnaires during a regularly scheduled clinic visit. These questionnaires will measure pain and other symptoms, such as your mood and quality of life. You will also be asked to give a tissue sample by inserting a swab into your mouth and rubbing firmly against the inside of your cheek or underneath your lower or upper lip for about a minute at most. Completing the 5 questionnaires and the swab sample collection takes about 30 minutes in total. This is an investigational study. Up to 500 patients will take part in the cross-sectional phase of this study. All will be enrolled at MD Anderson.